Article

The New York Times on 2023-10-15 02:32

Scientists investigating Alzheimer’s drug faulted in leaked report

A neuroscientist whose studies undergird an experimental Alzheimer’s drug was “reckless” in his failure to keep or provide original data, an offense ...

Related news

Scientists rethink Alzheimer’s, diversifying the drug search Merced Sun-Star
Kentucky , Massachusetts , Taiwan , New York , Lexington
HAlzheimer’s Drug Failure Leaves Scientists Seeking New Direction hamodia.com
Texas , New York , San Antonio , Washington
Scientists Question Data Behind an Experimental Alzheimer’s Drug The New York Times
SEC Investigating Cassava Sciences, Developer of Experimental Alzheimer’s Drug wsj.com
Medicare must study unproven, expensive Alzheimer’s drug bangordailynews.com
Americas , New York , Switzerland
Scientists rethink Alzheimer’s, diversifying the drug search - Tue, 10 Sep 2019 PST The Spokesman-Review
Kentucky , Massachusetts , Taiwan , New York , Lexington
Eli Lilly applies for FDA approval on Alzheimer’s drug Arkansas Online
Rochester , San Francisco , New York , Amsterdam , Indianapolis
EXPLAINER: New drug slows Alzheimer’s but comes with caveats seattletimes.com
Arecibo , Mount Sinai , New York , Japan
Scientists explore Alzheimer’s in women triblive.com
Framingham , King Charles , Spokane
U.S. approves drug for Alzheimer’s nwaonline.com
Japan
FAlzheimer’s scientists shrug off high failure rate ft.com
Wall Street , San Francisco , New York
Scientists Use Flickering Light to Fight Alzheimer’s infowars.com
New Zealand , China
WScientists announce experimental Alzheimer’s drug breakthrough wigantoday.net
United States